Author Profile

Destiny Hinton

Destiny HInton

Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.

Stories by Destiny Hinton

Group of people in lab
Group of people in lab
Research

Environment helps fuel hepatoblastoma in premature infants

Erin Podolak, MA

The incidence of pediatric and adult liver cancer is increasing worldwide. Research suggests how premature birth may influence the risk for children.

Melissa Hudson video screenshot
Melissa Hudson video screenshot
Research

It’s in the genes: research reveals obstacles on the road to health for cancer survivors

Alex Generous, PhD

St. Jude scientists are leading research into the genetics of childhood cancer survivorship to understand and prevent the risk of chronic disease in survivors.

Peter McKinnon, Kathryn Stephenson, Richard Finkel
Peter McKinnon, Kathryn Stephenson, Richard Finkel
Research

Two Years of the Pediatric Translational Neuroscience Initiative

Alex Generous, PhD

St. Jude initiative aims to change the outlook for children with catastrophic neurological diseases.

Backpack
Backpack
Outreach

What Parents and Caregivers Should Know about HPV Vaccination

Carrie Strehlau

Now is a great time for kids to get vaccinated against HPV and protected against six different cancers.

James R. Downing, MD, St. Jude president and CEO, inside St. Jude new research building
James R. Downing, MD, St. Jude president and CEO, inside St. Jude new research building
Outreach

Expanding the St. Jude strategic plan to $12.9 billion helps further advance its mission

James R. Downing, MD

Dr. James R. Downing details how St. Jude strategic plan expansion aims to accelerate research and treatment for childhood catastrophic diseases.

Xu Yang and Yizhen Li in a laboratory
Xu Yang and Yizhen Li in a laboratory
Research

T cells are key to maintaining cancer remissions from chemotherapy

Erin Podolak, MA

Stimulating the adaptive immune response can improve outcomes for ALL treated with chemotherapy.

Paul Thomas and Joshua Wolf
Paul Thomas and Joshua Wolf
Research

St. Jude researchers answer COVID questions

Erin Podolak, MA

St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.

Medicine bottle labeled HPV Prevention
Medicine bottle labeled HPV Prevention
Outreach

Take the prevent HPV pledge and let’s stop cancer before it starts

Heather Brandt, PhD and Melissa Hudson, MD

HPV vaccination rates dipped during the COVID-19 pandemic. St. Jude is working with more than 100 organizations, health experts and others to highlight vaccination as cancer prevention.

Paul Wise giving a lecture
Paul Wise giving a lecture
Clinical

SAFER Ukraine: a framework for responding to global conflicts

Erin Podolak, MA

What lessons can be learned from the remarkable success of SAFER Ukraine?

Fabio Demontis
Fabio Demontis
Research

Research points to a way to reduce cachexia, a cancer-induced muscle wasting disorder

Erin Podolak, MA

Muscle signaling provide clues for treatment of the muscle-wasting disorder cachexia, which affects cancer patients.